Each week the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Pharmaceutical company Daiichi Sankyo made a $10m pledge yesterday to Hatch Biofund 1, a US-based venture capital fund formed by non-profit medical research organisation Baruch S. Blumberg Institute. Hatch Biofund has a $50m target for its close, and Daiichi Sankyo’s commitment was made in connection with a collaboration agreement with life sciences incubator Pennsylvania Biotechnology Center.
Japan-headquartered crowdfunding platform operator ReadyFor secured ¥1bn ($9.1m) in series B funding on Monday from investors including Globis Capital Partners, Salesforce Ventures, Mitsubishi UFJ Innovation Partners, Nanto Capital Partners and Aozora Corporate Investment, vehicles for education services provider Globis, enterprise software producer Salesforce and financial services firms Mitsubishi UFJ Financial Group, Nanto Bank and Aozora Bank respectively. The round also featured Venture Labo Investment and JIC Venture Growth Investments, and it came after ReadyFor raised $3.8m in early 2019.
Growth equity firm Tybourne Capital Management provided an undisclosed amount of series D funding…
